JNJ
Price
$178.09
Change
+$0.92 (+0.52%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
426.69B
49 days until earnings call
PFE
Price
$24.98
Change
+$0.22 (+0.89%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
140.77B
63 days until earnings call
Interact to see
Advertisement

JNJ vs PFE

Header iconJNJ vs PFE Comparison
Open Charts JNJ vs PFEBanner chart's image
Johnson & Johnson
Price$178.09
Change+$0.92 (+0.52%)
Volume$42.73K
Capitalization426.69B
Pfizer
Price$24.98
Change+$0.22 (+0.89%)
Volume$322.23K
Capitalization140.77B
JNJ vs PFE Comparison Chart in %
Loading...
JNJ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PFE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
JNJ vs. PFE commentary
Sep 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JNJ is a Buy and PFE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 03, 2025
Stock price -- (JNJ: $177.17 vs. PFE: $24.76)
Brand notoriety: JNJ and PFE are both notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: JNJ: 83% vs. PFE: 90%
Market capitalization -- JNJ: $426.69B vs. PFE: $140.77B
JNJ [@Pharmaceuticals: Major] is valued at $426.69B. PFE’s [@Pharmaceuticals: Major] market capitalization is $140.77B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $656.73B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $89.14B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JNJ’s FA Score shows that 4 FA rating(s) are green whilePFE’s FA Score has 1 green FA rating(s).

  • JNJ’s FA Score: 4 green, 1 red.
  • PFE’s FA Score: 1 green, 4 red.
According to our system of comparison, JNJ is a better buy in the long-term than PFE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

JNJ’s TA Score shows that 2 TA indicator(s) are bullish while PFE’s TA Score has 7 bullish TA indicator(s).

  • JNJ’s TA Score: 2 bullish, 4 bearish.
  • PFE’s TA Score: 7 bullish, 4 bearish.
According to our system of comparison, PFE is a better buy in the short-term than JNJ.

Price Growth

JNJ (@Pharmaceuticals: Major) experienced а -0.46% price change this week, while PFE (@Pharmaceuticals: Major) price change was -4.33% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +0.29%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was +10.10%.

Reported Earning Dates

JNJ is expected to report earnings on Oct 21, 2025.

PFE is expected to report earnings on Nov 04, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+0.29% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JNJ($427B) has a higher market cap than PFE($141B). JNJ has higher P/E ratio than PFE: JNJ (18.97) vs PFE (13.10). JNJ YTD gains are higher at: 25.461 vs. PFE (-1.651). PFE has more cash in the bank: 13.2B vs. JNJ (3.25B). JNJ has less debt than PFE: JNJ (50.8B) vs PFE (60.9B).
JNJPFEJNJ / PFE
Capitalization427B141B303%
EBITDAN/A20.2B-
Gain YTD25.461-1.651-1,542%
P/E Ratio18.9713.10145%
RevenueN/A63.8B-
Total Cash3.25B13.2B25%
Total Debt50.8B60.9B83%
FUNDAMENTALS RATINGS
JNJ vs PFE: Fundamental Ratings
JNJ
PFE
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
16
Undervalued
4
Undervalued
PROFIT vs RISK RATING
1..100
28100
SMR RATING
1..100
3262
PRICE GROWTH RATING
1..100
2955
P/E GROWTH RATING
1..100
8097
SEASONALITY SCORE
1..100
65n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PFE's Valuation (4) in the Pharmaceuticals Major industry is in the same range as JNJ (16). This means that PFE’s stock grew similarly to JNJ’s over the last 12 months.

JNJ's Profit vs Risk Rating (28) in the Pharmaceuticals Major industry is significantly better than the same rating for PFE (100). This means that JNJ’s stock grew significantly faster than PFE’s over the last 12 months.

JNJ's SMR Rating (32) in the Pharmaceuticals Major industry is in the same range as PFE (62). This means that JNJ’s stock grew similarly to PFE’s over the last 12 months.

JNJ's Price Growth Rating (29) in the Pharmaceuticals Major industry is in the same range as PFE (55). This means that JNJ’s stock grew similarly to PFE’s over the last 12 months.

JNJ's P/E Growth Rating (80) in the Pharmaceuticals Major industry is in the same range as PFE (97). This means that JNJ’s stock grew similarly to PFE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
JNJPFE
RSI
ODDS (%)
Bearish Trend 5 days ago
43%
Bearish Trend 5 days ago
59%
Stochastic
ODDS (%)
Bearish Trend 5 days ago
56%
Bullish Trend 5 days ago
51%
Momentum
ODDS (%)
N/A
Bearish Trend 5 days ago
60%
MACD
ODDS (%)
Bearish Trend 5 days ago
52%
Bearish Trend 5 days ago
64%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
43%
Bearish Trend 5 days ago
60%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
42%
Bullish Trend 5 days ago
54%
Advances
ODDS (%)
Bullish Trend 12 days ago
41%
Bullish Trend 12 days ago
57%
Declines
ODDS (%)
Bearish Trend 8 days ago
43%
Bearish Trend 8 days ago
59%
BollingerBands
ODDS (%)
N/A
Bullish Trend 5 days ago
60%
Aroon
ODDS (%)
Bullish Trend 5 days ago
44%
Bullish Trend 5 days ago
54%
View a ticker or compare two or three
Interact to see
Advertisement
JNJ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PFE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
NKN.X0.025607-0.000430
-1.65%
NKN cryptocurrency
ONG.X0.161652-0.004736
-2.85%
Ontology Gas cryptocurrency
JUP.X0.474818-0.015053
-3.07%
Jupiter cryptocurrency
NBS.X0.000036-0.000002
-4.15%
New BitShares cryptocurrency
SKL.X0.029725-0.001519
-4.86%
SKALE cryptocurrency

JNJ and

Correlation & Price change

A.I.dvisor indicates that over the last year, JNJ has been loosely correlated with NVS. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if JNJ jumps, then NVS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JNJ
1D Price
Change %
JNJ100%
+0.98%
NVS - JNJ
55%
Loosely correlated
+0.06%
GSK - JNJ
49%
Loosely correlated
+0.58%
PFE - JNJ
46%
Loosely correlated
+0.65%
BIIB - JNJ
44%
Loosely correlated
-0.32%
SNY - JNJ
43%
Loosely correlated
-0.92%
More

PFE and

Correlation & Price change

A.I.dvisor indicates that over the last year, PFE has been loosely correlated with MRK. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if PFE jumps, then MRK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PFE
1D Price
Change %
PFE100%
+0.65%
MRK - PFE
58%
Loosely correlated
+1.09%
NVS - PFE
57%
Loosely correlated
+0.06%
GSK - PFE
56%
Loosely correlated
+0.58%
BIIB - PFE
54%
Loosely correlated
-0.32%
BMY - PFE
51%
Loosely correlated
+0.64%
More